Literature DB >> 31576486

Purinergic signaling in hepatic disease.

E Velázquez-Miranda1, M Díaz-Muñoz1, F G Vázquez-Cuevas2.   

Abstract

Extracellular purines (ATP and adenosine) are ubiquitous intercellular messengers. During tissular damage, they function as damage-associated molecular patterns (DAMPs). In this context, purines announce tissue alterations to initiate a reparative response that involve the formation of the inflammasome complex and the recruitment of specialized cells of the immune system. The present review focuses on the role of the purinergic system in liver damage, mainly during the onset and development of fibrosis. After hepatocellular injury, extracellular ATP promotes a signaling cascade that ameliorates tissue alterations to restore the hepatic function. However, if cellular damage becomes chronic, ATP orchestrates an aberrant reparative process that results in severe liver diseases such as fibrosis and cirrhosis. ATP and adenosine, their receptors, and extracellular ectonucleotidases are mediators of unique processes that will be reviewed in detail.

Entities:  

Keywords:  Ectonucleotidases; Fibrosis; Inflammation; Liver; Purinergic receptors

Year:  2019        PMID: 31576486      PMCID: PMC6923300          DOI: 10.1007/s11302-019-09680-3

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  111 in total

1.  ATP-mediated glia signaling.

Authors:  M L Cotrina; J H Lin; J C López-García; C C Naus; M Nedergaard
Journal:  J Neurosci       Date:  2000-04-15       Impact factor: 6.167

Review 2.  The invertebrate midintestinal gland ("hepatopancreas") is an evolutionary forerunner in the integration of immunity and metabolism.

Authors:  Tamás Rőszer
Journal:  Cell Tissue Res       Date:  2014-09-02       Impact factor: 5.249

3.  Extracellular ATP induces P2X7 receptor activation in mouse Kupffer cells, leading to release of IL-1β, HMGB1, and PGE2, decreased MHC class I expression and necrotic cell death.

Authors:  Yusuke Toki; Takato Takenouchi; Hitoshi Harada; Sei-ichi Tanuma; Hiroshi Kitani; Shuji Kojima; Mitsutoshi Tsukimoto
Journal:  Biochem Biophys Res Commun       Date:  2015-02-11       Impact factor: 3.575

4.  Adenosine inhibits cytosolic calcium signals and chemotaxis in hepatic stellate cells.

Authors:  Ardeshir Z Hashmi; Wyel Hakim; Emma A Kruglov; Azuma Watanabe; William Watkins; Jonathan A Dranoff; Wajahat Z Mehal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-10-19       Impact factor: 4.052

Review 5.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

6.  Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation.

Authors:  Shuang Jiang; Yu Zhang; Jin-Hua Zheng; Xia Li; You-Li Yao; Yan-Ling Wu; Shun-Zong Song; Peng Sun; Ji-Xing Nan; Li-Hua Lian
Journal:  Pharmacol Res       Date:  2016-12-08       Impact factor: 7.658

7.  An adenosine derivative compound, IFC305, reverses fibrosis and alters gene expression in a pre-established CCl(4)-induced rat cirrhosis.

Authors:  Julio Isael Pérez-Carreón; Lidia Martínez-Pérez; María Lilia Loredo; Lucia Yañez-Maldonado; Gabriela Velasco-Loyden; Susana Vidrio-Gómez; Jorge Ramírez-Salcedo; Francisco Hernández-Luis; Israel Velázquez-Martínez; Juan Antonio Suárez-Cuenca; Rolando Hernández-Muñoz; Victoria Chagoya de Sánchez
Journal:  Int J Biochem Cell Biol       Date:  2009-11-13       Impact factor: 5.085

8.  P2Y2 purinergic receptor activation is essential for efficient hepatocyte proliferation in response to partial hepatectomy.

Authors:  Bryan C Tackett; Hongdan Sun; Yu Mei; Janielle P Maynard; Sayuri Cheruvu; Arunmani Mani; Andres Hernandez-Garcia; Nadarajah Vigneswaran; Saul J Karpen; Sundararajah Thevananther
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-09       Impact factor: 4.052

9.  Loss of A(1) adenosine receptor attenuates alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice.

Authors:  Ping Yang; Peng Chen; Tao Wang; Yibei Zhan; Mengyi Zhou; Lin Xia; Rui Cheng; Yating Guo; Lin Zhu; Jianfa Zhang
Journal:  Toxicol Sci       Date:  2012-09-06       Impact factor: 4.849

10.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

View more
  11 in total

Review 1.  Purinergic signaling in thyroid disease.

Authors:  Ying Le; Donghui Lu; Meng Xue
Journal:  Purinergic Signal       Date:  2022-03-26       Impact factor: 3.765

Review 2.  Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis.

Authors:  Ryutaro Kuraji; Satoshi Sekino; Yvonne Kapila; Yukihiro Numabe
Journal:  Periodontol 2000       Date:  2021-10       Impact factor: 7.589

Review 3.  Purinergic Signaling in Liver Pathophysiology.

Authors:  Shanu Jain; Kenneth A Jacobson
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-11       Impact factor: 5.555

4.  Melatonin Suppresses NLRP3 Inflammasome Activation via TLR4/NF-κB and P2X7R Signaling in High-Fat Diet-Induced Murine NASH Model.

Authors:  Moumita Saha; Krishnendu Manna; Krishna Das Saha
Journal:  J Inflamm Res       Date:  2022-05-31

5.  Role of Tunneling Nanotube-like Structures during the Early Events of HIV Infection: Novel Features of Tissue Compartmentalization and Mechanism of HIV Spread.

Authors:  George Okafo; Silvana Valdebenito; Maribel Donoso; Ross Luu; David Ajasin; Brendan Prideaux; Santhi Gorantla; Eliseo A Eugenin
Journal:  J Immunol       Date:  2020-10-09       Impact factor: 5.422

Review 6.  Autocrine and paracrine purinergic signaling in the most lethal types of cancer.

Authors:  M Reyna-Jeldes; M Díaz-Muñoz; J A Madariaga; C Coddou; F G Vázquez-Cuevas
Journal:  Purinergic Signal       Date:  2021-05-12       Impact factor: 3.765

Review 7.  Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor.

Authors:  Raf Van Campenhout; Serge Muyldermans; Mathieu Vinken; Nick Devoogdt; Timo W M De Groof
Journal:  Biomolecules       Date:  2021-01-06

Review 8.  Structure-activity features of purines and their receptors: implications in cell physiopathology.

Authors:  Mauricio Díaz-Muñoz; Rolando Hernández-Muñoz; Armando Butanda-Ochoa
Journal:  Mol Biomed       Date:  2022-01-26

9.  Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI.

Authors:  Junnan Cai; Yu-Lian Wang; Xiao-Dong Sheng; Lei Zhang; Xiongwen Lv
Journal:  J Ethnopharmacol       Date:  2022-08-21       Impact factor: 5.195

Review 10.  The P2X7 Receptor and NLRP3 Axis in Non-Alcoholic Fatty Liver Disease: A Brief Review.

Authors:  Marco Rossato; Angelo Di Vincenzo; Claudio Pagano; Hamza El Hadi; Roberto Vettor
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.